MeSH note : chimeric anti-kinase insert domain-containing receptor (KDR) antibody that blocks
VEGFR-KDR interaction and inhibits VEGFR-induced endothelial cell proliferation; used
for treatment of patients with liver metastases from colorectal carcinoma (in Phase
I trial 1/2004);